April 2, 2012
AlloCure Raises $25 Million Series B Venture Financing
New Funding to Support Phase 2 Trial of Novel Therapy for Acute Kidney Injury
Press release

January 5, 2012
AlloCure's Investigational Treatment for Acute Kidney Injury Receives Fast Track Designation by FDA
Press release

November 14, 2011
AlloCure Presents Safety and Preliminary Efficacy of AC607 for the Treatment of Acute Kidney Injury at ASN
Phase 1 Trial Results Presented at "Kidney Week 2011"
Press release

February 14, 2011
AlloCure Appoints Kevin J. Heyeck as Chief Business Officer
Press release

July 6, 2010
AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer
Press release